Journal profile · Medicine-Pharmacology (medical)
Journal of Nephropharmacology
ISSN 2345-4202 · Society of Diabetic Nephropathy Prevention · Iran, Islamic Republic of
Journal of Nephropharmacology: fully open access; APC about USD 400; median 73 days to acceptance (40 articles, last 24 months); 21 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Journal of Nephropharmacology is published by Society of Diabetic Nephropathy Prevention. By OpenAlex counts of its recent articles, its largest topics are Chronic Kidney Disease and Diabetes, Dialysis and Renal Disease Management and Acute Kidney Injury Research, together about 40.2% of its articles. Its main subfields are Nephrology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Medicine-Pharmacology (medical)
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Kidney Disease and DiabetesMedicine15.5%
- Dialysis and Renal Disease ManagementMedicine13.3%
- Acute Kidney Injury ResearchMedicine11.4%
- Renal Diseases and GlomerulopathiesMedicine9.5%
- COVID-19 Clinical Research StudiesMedicine4.7%
- Chemotherapy-induced organ toxicity mitigationMedicine4.5%
- Parathyroid Disorders and TreatmentsMedicine4.1%
- Renal Transplantation Outcomes and TreatmentsMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Nephrology | Q3 | 62/88 | 30th |
| Pharmacology (medical) | Q3 | 209/278 | 25th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.2LetPub ·
- SJR 2026-06
- 0.2LetPub ·
- SNIP 2026-06
- 0.29LetPub ·
- h-index
- 11OpenAlex ·
- i10-index
- 13OpenAlex ·
- 2-year mean citedness
- 0.69OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 274 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 13 | 13 | 83 |
| 2025 | 21 | 21 | 108 |
| 2024 | 31 | 31 | 110 |
| 2023 | 29 | 29 | 80 |
| 2022 | 27 | 27 | 86 |
| 2021 | 24 | 24 | 96 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
73 daysMedian, submission to acceptance · P25–P75 57 days – 102 days
- Acceptance to online
- median 14 days (40 articles)
- Submission to online
- median 88 days
- Sample
- 40 articles with submission and acceptance dates (45 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 4 weeksLetPub ·
- Submission to publication (journal-reported)
- about 4 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 400 | Yes | CC BY | |
| LetPub | USD 400 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Society of Diabetic Nephropathy Prevention
- Country or region
- Iran, Islamic Republic of
- Language
- English
- ISSN
- 2345-4202
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Nephropharmacology
How long does peer review take at Journal of Nephropharmacology?
Based on the dates recorded on 40 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 73 days (interquartile range 57–102 days); authors report an average review time of about 4 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Nephropharmacology?
According to LetPub and DOAJ records, Journal of Nephropharmacology is indexed in Scopus and DOAJ.
Is Journal of Nephropharmacology open access, and what is the APC?
Journal of Nephropharmacology is a fully open-access journal. APC about USD 400.
Sources and updates
The facts on this page come from LetPub, DOAJ, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .